$CNNN
ConneXionONE Corp.

2023 Q2 Form 10-Q Financial Statement

#000168316823003222 Filed on May 12, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $16.66K $34.33K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $16.66K $34.33K $30.12K
YoY Change 42607.69% 13.97%
Operating Profit -$16.66K -$34.33K -$30.12K
YoY Change 42607.69% 13.97%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change
Pretax Income -$16.66K -$34.33K -$30.12K
YoY Change 42607.69% 13.97%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$16.66K -$34.33K -$10.12K
YoY Change -16.88% 239.2% 1944.44%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 71.85M shares 71.85B shares 71.85M shares
Diluted Shares Outstanding 71.85M shares 71.85M shares 71.85M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.55K $1.710K
YoY Change
Cash & Equivalents $28.55K $1.705K $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables $442.0K $512.0K
Total Short-Term Assets $470.5K $513.7K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $470.5K $513.7K
Total Long-Term Assets $0.00 $0.00
Total Assets $470.5K $513.7K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.25K $88.25K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $878.8K $905.3K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.003M $1.003M
YoY Change
Total Long-Term Liabilities $1.003M $1.003M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $878.8K $905.3K
Total Long-Term Liabilities $1.003M $1.003M
Total Liabilities $1.881M $1.908M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$73.98M -$73.97M
YoY Change
Common Stock $71.85K $71.85K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.411M -$1.394M -$1.278M
YoY Change
Total Liabilities & Shareholders Equity $470.5K $513.7K
YoY Change

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$16.66K -$34.33K -$10.12K
YoY Change -16.88% 239.2% 1944.44%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $13.35K -$34.33K -$120.00
YoY Change 28505.83%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$132.0K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.50K $163.0K $120.00
YoY Change 135733.33%
NET CHANGE
Cash From Operating Activities 13.35K -$34.33K -$120.00
Cash From Investing Activities 0.000 -$132.0K $0.00
Cash From Financing Activities 13.50K $163.0K $120.00
Net Change In Cash 26.85K -$3.327K $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities $13.35K -$34.33K -$120.00
Capital Expenditures $0.00 $0.00
Free Cash Flow $13.35K -$34.33K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001182731
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q4 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NC
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
30-1252905
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
39899 BALENTINE DRIVE
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
SUITE 200
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
NEWARK
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94560
CY2023Q1 dei City Area Code
CityAreaCode
408
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
533-8155
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
71850644 shares
CY2023Q1 us-gaap Cash
Cash
1705 usd
CY2022Q4 us-gaap Cash
Cash
5032 usd
CY2023Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
512000 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
380000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
513705 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
385032 usd
CY2023Q1 us-gaap Assets
Assets
513705 usd
CY2022Q4 us-gaap Assets
Assets
385032 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
88250 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
88250 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
817068 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
654068 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
905318 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
742318 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1907957 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1744957 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71850644 shares
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-50075
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
CONNEXIONONE CORP.
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71850644 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71850644 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71850644 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
71851 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
71851 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
72499335 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
72499335 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73965438 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73931111 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1394252 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1359925 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
513705 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
385032 usd
CY2023Q1 us-gaap Revenues
Revenues
0 usd
CY2022Q1 us-gaap Revenues
Revenues
0 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
16200 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
30000 usd
CY2023Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
18127 usd
CY2022Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
120 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
34327 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
30120 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-34327 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-30120 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34327 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30120 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-34327 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-30120 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.000
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71850644 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71850644 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71846644 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71846644 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1267435 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1267435 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-30120 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1297555 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1359925 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-34327 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1394252 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-34327 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-30120 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
0 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
30000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34327 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-120 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
132000 usd
CY2022Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
-0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-132000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
163000 usd
CY2022Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
120 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
163000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
120 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3327 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5032 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1705 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_zyzhHr9Q9MRe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Use of estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s significant estimates include income taxes provision and valuation allowance of deferred tax assets; the fair value of financial instruments; the carrying value and recoverability of long-lived assets, including the values assigned to an estimated useful lives of computer equipment; and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management regularly reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73965438 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71850644 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71850644 shares
CY2023Q1 AFTC Liabilities Carryover From Prior Abandoned Operations
LiabilitiesCarryoverFromPriorAbandonedOperations
665735 usd
CY2022Q4 AFTC Liabilities Carryover From Prior Abandoned Operations
LiabilitiesCarryoverFromPriorAbandonedOperations
665735 usd
CY2023Q1 AFTC Accrual Carryover From Prior Abandoned Operations
AccrualCarryoverFromPriorAbandonedOperations
336904 usd
CY2022Q4 AFTC Accrual Carryover From Prior Abandoned Operations
AccrualCarryoverFromPriorAbandonedOperations
336904 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
one-for-one thousand (1:1,000)
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
73965438 usd

Files In Submission

Name View Source Status
0001683168-23-003222-index-headers.html Edgar Link pending
0001683168-23-003222-index.html Edgar Link pending
0001683168-23-003222.txt Edgar Link pending
0001683168-23-003222-xbrl.zip Edgar Link pending
aftc-20230331.xsd Edgar Link pending
connexionone_ex3101.htm Edgar Link pending
connexionone_ex3102.htm Edgar Link pending
connexionone_ex3201.htm Edgar Link pending
connexionone_ex3202.htm Edgar Link pending
connexionone_i10q-33123.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
aftc-20230331_def.xml Edgar Link unprocessable
aftc-20230331_cal.xml Edgar Link unprocessable
aftc-20230331_pre.xml Edgar Link unprocessable
aftc-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
connexionone_i10q-33123_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending